Clinical Trials · NCT06911203
A Study of BGM0504 in Participants With Obesity
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- BrightGene Bio-Medical Technology Co., Ltd.
- Enrollment
- 96
- Start date
- Apr 2025
- Locations
- 1 site, China
- Primary endpoint
- Change From Baseline in Body Weight